Skip to content

Homeopathic treatment of problems of sinuses

Comparison of olfactory vis-à-vis oral mode of administration of individualized homoeopathic medicines in chronic rhinosinusitis: A randomized, double-blind, double-dummy pilot trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042028
Enrollment
60
Registered
2022-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J329- Chronic sinusitis, unspecified

Interventions

Intervention1: Individualized homeopathic medicines in centesimal potencies: Intervention is planned as administering the individualized homeopathic medicines in centesimal potencies. Each patient wil

Sponsors

D N De Homoeopathic Medical College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a)Patients suffering from chronic rhinosinusitis (ICD-10 code: J32.9) since last 3 months or more. b)Diagnosis of chronic rhinosinusitis based on AAO-HNS diagnostics criteria. c)Age between 18-65 years d)Patients of either sex e)Literate patients; ability to read English, Hindi and/or Bengali f)Providing written informed consent

Exclusion criteria

Exclusion criteria: a)Underwent major ENT surgery within last 6 month. b)Cases with complications of CRS. c)Insisting on or need of surgical intervention d) Vulnerable population - unconscious, differently abled, terminally or critically ill patients, mentally incompetent people e) Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. f) Pregnant and puerperal women, lactating mothers. g) Substance abuse and/or dependence. h) Self-reported immune-compromised state. i) Already undergoing homeopathic treatment for chronic disease within last 6 months.

Design outcomes

Primary

MeasureTime frame
Sino-Nasal Outcome Test (SNOT-22)Timepoint: At baseline, every month, up to 3 months

Secondary

MeasureTime frame
0-10 Numeric rating scales measuring sneezing, rhinorrhea, post-nasal drip, facial pain or pressure and disturbance in sense of smellTimepoint: At baseline, every month, up to 3 months ;Measure yourself medical outcome profile version 2 (MYMOP-2)Timepoint: At baseline, every month, up to 3 months

Countries

India

Contacts

Public ContactDr Satyajit Naskar

D. N. De Homoeopathic Medical College and Hospital

satya.naskar@gmail.com8981859153

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026